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Background: The application of laparoscopic surgery for advanced gastric cancer (AGC) remains questionable on
account of technical difficulty of D2 lymphadenectomy, and there has been few large-scale follow-up results
regarding the oncological adequacy of laparoscopic surgery compared with that of open surgeries for AGC. The
aim of this study is to evaluate technical feasibility and oncological efficacy of laparoscopy-assisted gastrectomy
(LAG) for advanced gastric cancer without serosal invasion.
Methods: From January 2008 to December 2012, 1114 patients with gastric cancer underwent D2 gastrectomy,
including 336 T2 and T3 patients in term of depth of invasion. Of all 336 patients, 224 underwent LAG, while
open gastrectomy (OG) performed on the other 112 patients. The comparison was based on the clinicopathologic
characteristics, surgical outcome, and follow-up results.
Results: There are not significant differences in clinicopathological characteristics between the two groups
(P > 0.05). The operation time and first ambulation time was similar in the two groups. However, estimated blood
loss, bowel function recovery time and duration of hospital stay were significantly less in the LAG group. No
significant difference in morbidity and mortality was found between the LAG group and OG group (11.1% vs.
15.3%, P = 0.266; 0.9% vs. 1.8%, P = 0.859). The mean number of resected lymph nodes (LNS) between the LAG
group and OG group was similar (30.6 ± 10.1 vs. 30.3 ± 8.6, P = 0.786). Furthermore, the mean number of removed
LNS in each station was not significantly different in the distal gastrectomy and total gastrectomy (P > 0.05).
No statistical difference was seen in 1 year survival rate (91.5% vs. 89.8% P > 0.05) and the survival curve after
surgery between the LAG group and OG group.
Conclusion: Laparoscopy-assisted D2 radical gastrectomy is feasible, effective and has comparative oncological
efficacy compared with open gastrectomy for advanced gastric cancer without serosal invasion.
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Since laparoscopy-assisted gastrectomy (LAG) for early
gastric cancer was initially reported in 1994 [1], it has been
increasingly used to treat early gastric cancer as it is less
invasive than conventional open gastrectomy (OG) [2,3].
However, its wider acceptance as an alternative to the open
approach remains contentious. The reasons for slow ac-
ceptance of this procedure include concerns about safety
and doubts about the effectiveness of lymphadenectomy* Correspondence: hcmlr2002@163.com
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reproduction in any medium, provided the orcompared to conventional open gastrectomy. This study
compared the clinical features of 224 patients who under-
went LAG with 112 patients who underwent OG with D2
lymph node dissection, for pathologically confirmed stage
T2-3 gastric carcinoma. The aim of this study was to
evaluate the feasibility and short-term outcome of LAG for
advanced gastric cancer (AGC) without serosal exposure.Methods
Materials
From January 2008 to December 2010, 1,114 patients
diagnosed with primary gastric cancer were treated withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gery, Fujian Medical University Union Hospital, Fuzhou,
China. Of these patients, 336 had pathologically con-
firmed stage T2 (depth of invasion in submucosa) or T3
(depth of invasion in muscularis propria) cancer accord-
ing to the 7th edition of the Union for International
Cancer Control (UICC) [4]; of the 336 patients, 224
underwent LAG, and 112 patients underwent OG. Selec-
tion of laparoscopic versus the open approach for
patients diagnosed preoperatively with AGC was by pa-
tient choice.
Nodal material was separately dissected from the
enbloc specimen at the end of the procedure by the sur-
geons, and the remaining nodes were identified and
retrieved by specialized pathologists from formalin-fixed
surgical specimens without using any specific technique
to increase nodal retrieval rate. The lymph nodes of the
stomach are defined and given station numbers accord-
ing to the 3rd English edition of Japanese classification
of gastric carcinoma [5]. Staging was done according to
the 7th edition of the UICC tumor, mode, metastasis
(TNM) classification [4]. Postoperative complications
have been classified using the therapy-oriented severity
grading system (TOSGS) as follows: grade 1, no need for
specific intervention; grade 2, need for drug therapy
such as antibiotics; grade 3, need for invasive therapy;
grade 4, organ dysfunction with ICU stay; grade 5, death.
This type of system is applied in medical oncology and
has resulted in the National Cancer Institute’s uniform
system of complication reporting.
All procedures were performed after obtaining
informed consent following the explanation of the surgi-
cal and oncologic risks. Inclusion criteria were as fol-
lows: histologically confirmed adenocarcinoma of the
stomach; pathologically confirmed stage T2-T3; no evi-
dence of distant metastasis by means of abdominal com-
puted tomography(CT) and/or abdominal ultrasound
and posteroanteriorchest radiograph; D2 lymphadenect-
omy with curative R0 according to pathological diagno-
sis after the operation. Exclusion criteria were as follows:
intraoperative evidence of peritoneal disseminated or
distant metastasis; incomplete of pathological data; diag-
nosis of positive serosal invasion during the operation.
Follow-up was carried out by trained investigators
through mailings, telephone calls, visits to patients or
recording of the patients’ consultations at the outpatient
service every 6 months. The survival time was the time
from the surgical intervention until the last contact, the
date of death, or the date that the survival information
was collected.
Surgical procedure
The D2 lymphadenectomy was always performed
according to the lymph node classification of theJapanese Gastric Cancer Association [5]. All operations
were performed under general anesthesia. Patients were
placed in the supine position, with legs apart and 20 to
30° head-up tilt. The surgeon stood on the left of the pa-
tient, the assistant surgeon stood on patient’s right, and
the videolaparoscope operator stood between the
patient’s legs. Five trocars were used; one 10-mm trocar
for the laparoscope was inserted below the umbilicus.
One 12-mm trocar was inserted in the left pre-axillary
line 2 cm below the costal margin as a major hand port.
A 5-mm trocar was placed at the contralateral site for
traction and exposure of the liver. A 5-mm trocar was
inserted as an accessory port in the left and right mid
clavicular line 2 cm above the level of the umbilicus.
Laparoscopic total gastrectomy
The stomach and the peritoneal cavity were inspected to
rule out adjacent organ invasion and peritoneal seeding
using a 30° forward oblique laparoscope. Then under
pneumoperitoneum of 12 to 15 mmHg, the gastrocolic
ligament was divided using ultrasonic-activated scissors
along the border of the transverse colon, thus including
the greater omentum in the specimen to be resected.
The dissection moved to the hepatic flexure and the pyl-
orus. Then the superior leaf of the mesocolon was dis-
sected. After the right gastroepiploic vein was exposed
and divided with double clips, the right gastroepiploic
artery was vascularized and cut with titanium clips at its
origin from the gastroduodenal artery, just above the
pancreatic head, to dissect Group 6 (Figure 1). The
stomach was lifted upwards (towards the head)to expose
the gastropancreatic fold. The left gastric vein was care-
fully prepared and separately divided at the upper border
of the pancreatic body and then the left gastric artery
was vascularized to remove Group 7. The lymph nodes
along the proximal splenic artery (Group 11p) were
removed. Subsequently, the dissection was continued to
the right along the artery to remove the nodes along the
celiac axis and the common hepatic artery (Group 9, 8a).
The right gastric artery was then exposed and divided at
its origin with double clips, thus creating room for the
dissection of the suprapyloric lymph nodes (Group 5).
Along the border of the liver, the lesser omentum was
dissected and the lymph nodes of the anterior region of
the hepatoduodenal ligament (Group 12a) were dis-
sected and removed (Figure 2). The dissection was con-
tinued toward the distal pancreas to uncover the distal
splenic artery and splenic vein, then the fatty connective
tissue, including the lymph nodes along the distal splenic
artery (Group 11d) and the lymph nodes around splenic
hilum (Group 10), were completely removed. The left
gastroepiploic artery, posterior gastric artery, and all
short gastric vessels were divided with either harmonic
scissors or clips, and the lymph nodes were removed
Figure 1 Dissection of lymph node number 6. RGEV, right gastroepiploic vein; RGEA, right gastroepiploic artery; ASPDV, anterior superior
pancreaticoduodenal vein; SMV, superior mesenteric vein; RCV, right colic vein; HT, Herne’s trunk; MCV, middle colic vein.
Figure 2 Dissection of lymph nodes numbers7, 8a, 9, 12a, 11p. LGA, left gastric artery; RGA, right gastric artery; CV, coronary vein; CHA,
common hepatic artery; PHA, proper hepatic artery; GDA, gastroduodenal artery; SPA, splenic artery.
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the cardiac nodes were dissected enbloc including the
right cardiac (Group 1) and left cardiac nodes (Group 2).
After dissection of the gastric and gastroepiploic vessels,
the phrenoesophageal membrane and vagal nerve were
divided.
Laparoscopic distal gastrectomy
All steps were performed as in the total gastrectomy
procedure but without the mobilization of the distal
esophagus, gastric fundus and Group10, 11d and some
Group 4sa lymph nodes. The stomach proximal transec-
tion site was selected according to the location of the
tumor and the procedure was performed with a linear
stapler.
After the laparoscopic operation, a small laparotomy
incision was made under the xyphoid (5 to 7 cm). Distal
gastrectomy with Billroth I, Billroth II or total gastrec-
tomy with Roux-en-Y anastomosis were extra corpor-
eally performed using the hand-sewn method. The
specimen was pulled out of the peritoneal cavity through
the small laparotomy incision. OG was performed using
the same methods as LAG. The region of lymphadenect-
omy in OG was mostly the same as that for LAG.
Statistical analysis
All statistical analyses were conducted using the statis-
tical program SPSS 18.0. The data were collected and
expressed as mean ± SD. A statistical analysis wasFigure 3 Dissection of the splenic hilum preserving the splenic arteryperformed using the chi-square test, or the unpaired
Student’s t-test as appropriate. Survival was evaluated
using the Kaplan-Meier method, including the log-rank




The clinicopathologic characteristics of the patients are
presented in Table 1. The series included 72 men and
264 women, with a mean age of 61.3 years (range 32 to
89 years). The age, gender, resection extent, tumor
depth, tumor size, body mass index (BMI), location of
neoplasm, gross type, histologic type, American Society
of Anesthesiologists(ASA) score, comorbidity, lymph
node status (N stage), TNM stage and gastrointestinal
reconstruction type did not differ between the LAG
group and OG group (P > 0.05).
Intraoperative and postoperative characteristics
The operation time and first ambulation time did not
differ between the LAG group and OG group. However,
estimated blood loss, transfusion amounts, bowel func-
tion recovery time and duration of hospital stay were
significantly lower in the LAG group(P < 0.05) (Table 2).
Morbidity and mortality
The overall postoperative morbidity and mortality rates
among all patients were 12.5% and 1.2%, respectively.and vein. SPA, splenic artery; SPA, splenic vein.
Table 1 Patient clinicopathological characteristics
Characteristics LAG(n = 224) OG(n) = 112 P-value
Sex: 0.778
Female (n) 175 89
Male (n) 49 23
Age(years, mean ± SD) 61.6 ± 10.6 60.8 ± 10.2 0.525
Tumor size(cm, mean ± SD) 4.7 ± 2.0 4.4 ± 2.0 0.631
Body mass index (kg/m2) 22.3 22.0 0.498
Tumor location (n): 0.083
Greater curvature 82 52
Lesser curvature 143 60





















Tumor depth (n): 0.133
T2 81 50
T3 143 62











Resection extent (n): 1.000
TG 106 61
DG 118 51






n, number of patients; ASA, American Society of Anesthesiologists; DG, distal
gastrectomy; TG, total gastrectomy; TNM, tumor, node metastasis staging; LAG,
laparoscopy-assisted gastrectomy; OG, open gastrectomy. P-values are for
comparison of the LAG and OG groups.
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tween the LAG and OG groups (11.1% vs. 15.3%, P =
0.266), and we also observed no difference between the
two groups using TOSGS. The mortality rate in the
LAG group was 0.9% compared with 1.8% in the OG
group, but the difference was not statistically significant
(P = 0.859) (Table 3).
Dissection of lymph nodes
The mean number of harvested lymph nodes was 30.5 ±
9.6 in all patients with a median of 29 (range 10 to 64).
The mean number of retrieved lymph nodes was not dif-
ferent between the two groups (30.6 ± 10.1 in the LAG
group vs. 30.3 ± 8.6 in the OG group) (P = 0.786). Fur-
thermore, the mean number of removed lymph nodes in
each station was not significantly different in distal gas-
trectomy or total gastrectomy (P > 0.05) (Figure 4, 5).
Survival time
The follow-up rate was 98.9% (316 patients). Of these,
the LAG follow-up rate was 94.6% (212 patients) and
the OG follow-up rate was 92.9% (104 patients). The
median follow-up period was 19 months (range 1 to
48 months). The respective 1-year survival rates were
91.5% (LAG) and 89.8% (OG).There was no significant
differences in the overall survival curve between the two
groups (Figure 6) (P = 0.297).
Discussion
LAG shares obvious advantages of being minimally inva-
sive and has the same short- and long-term efficacy
compared with traditional open surgery in the treatment
of early gastric cancer [6-9].Therefore, it has gradually
become acknowledged by counterpart clinicians. Since
2002, the Japanese gastric cancer treatment guidelines
have recommended laparoscopy-assisted gastrectomy as
the standard procedure for early gastric carcinoma.
As experience with LAG for early gastric cancer has
substantially increased, some surgeons have become
concerned about laparoscopic surgery for AGC [10-14].
Ninety percent of patients diagnosed with gastric carcin-
oma in China have advanced-stage disease. The study of
laparoscopic techniques in AGC would seem sensible
Table 2 Intraoperative and postoperative characteristics
Variables LAG(n = 224) OG(n = 112) P-value
Operation time(minutes) 207.2 ± 137.3 213.0 ± 54.7 0.667
Blood loss(ml) 82.7 ± 101.3 201.7 ± 235.3 0.0
Transfused patients (n) 4 8 0.029
Time to first ambulation (days1) 2.7 ± 1.2 2.9 ± 1.2 0.099
Time to first flatus (days1) 2.6 ± 1.1 3.2 ± 1.1 0.0
Time to fluid diet (days1) 4.7 ± 1.5 5.1 ± 1.8 0.034
Time to soft diet (days1) 8.7 ± 1.6 10.3 ± 1.6 0.0
Hospital stay (days1) 13.3 ± 5.7 17.4 ± 5.0 0.0
Results are presented as mean ± SD unless stated otherwise1Postoperative
days; n, number of patients;P-values are for comparison of the LAG and OG
groups.
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section as the preferred treatment for fit patients with
AGC, in centers that can demonstrate low operative
mortality [15,16]. Furthermore, the Japanese gastricTable 3 Morbidity and mortality
Variables LAG(n = 224) OG(n = 112) P-value
Surgical complication 10 11 0.056
Duodenal stump fistula 1 1
Anastomotic leakage 1 1
Pancreatic fistula 1 1
Lymphatic fistula 2 3
Abdominal infection 2 1
Gastric stasis 1 1
Anastomotic bleeding 1 1
Anastomotic stenosis 1 1
Intestinal obstruction 0 1
Surgical complication grade 0.277
TOSGS 1 6 3
TOSGS 2 4 7
TOSGS 3 0 1
TOSGS 4 0 0
TOSGS 5 0 0





Medical complication grade 0.590
TOSGS 1 8 2
TOSGS 2 5 2
TOSGS 3 0 0
TOSGS 4 0 0
TOSGS 5 2 2
Mortality 2 2 0.859
Results presented as number of patients DIC, disseminated intravascular
coagulation; TOSGS, therapy-oriented severity grading system. P-values are for
comparison of the LAG and OG groups.cancer treatment guidelines have adopted D2 lymph
node dissection as the standard technique for AGC.
However, the application of laparoscopic surgery for
AGC remains questionable on account of the technical
difficulty of D2 lymphadenectomy, and there has been
few large-scale follow-up data on the oncologic adequacy
of laparoscopic surgery compared with that of open sur-
gery for AGC. Nevertheless, some small case-studies
also showed that laparoscopic D2 lymphadenectomy is a
safe procedure for AGC if the surgery is performed by
experienced surgeons [13,17,18]. The Japanese gastric
cancer treatment guidelines regard LAG as an investiga-
tional treatment [19]. Some scholars [20-22] studying
the laparoscopic learning curve have found that once
surgeons span the learning curve reaching a plateau
phase, the superiority of laparoscopic gastric carcinoma
surgery will gradually appear more often compared with
open surgery.
We have been performing LAG for gastric cancer
since 2007. In the present study, we selected patients
treated after January 2008, by which time we had over-
come the learning curve having performed approxi-
mately 300 laparoscopic D2 gastrectomy procedures for
gastric cancer, to reduce the influence of lack of surgical
experience on the results. In this study, we compared
224 patients who underwent LAG with 112 who under-
went OG for AGC without serosal exposure, in the same
period. The data show that the LAG and OG groups
shared similar operating times and first ambulation
times, while the LAG group had less intraoperative
blood loss, earlier recovery time for bowel movement,
and a shorter postoperative stay in hospital. LAG was
also shown to have obvious advantages of being minim-
ally invasive for treatment of AGC without invasion of
serosa.
The incidence of postoperative morbidity and mortal-
ity in the LAG group in the present study was similar to
that of other reports. Although no significant difference
in postoperative morbidity or mortality was observed be-
tween the LAG and OG groups (11.1% vs. 15.3%, and
0.9% vs. 1.8%, respectively, P > 0.05),our results show
that LAG for AGC has similar intraoperative and post-
operative complications to open surgery, and may even
be better than OG. LAG D2 radical lymphadenectomy is
a safe technique with fast postoperative recovery in the
treatment of AGC without invasion of serosa. Therefore,
LAG for AGC may be acceptable from this viewpoint.
The advantages of minimally invasive laparoscopic sur-
gery have gradually been recognized, but laparoscopic
D2 lymph node dissection is difficult to handle due to
the complicated vessels, numerous anatomical layers and
the complex lymph node metastasis pathway around the
stomach. Therefore, many scholars still doubt whether
LAG can achieve as considerable a radical effect as open
Figure 4 Distribution of harvested perigastric lymph nodes in the laparoscopy-assisted distal gastrectomy (LADG) and the open distal
gastrectomy(ODG) groups. The mean number of removed lymph nodes in each station was not significantly difference between the two
groups (P > 0.05).
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assisted D2 lymph node dissection and 130 cases of
open surgery for AGC. The average number of retrieved
lymph node in the laparoscopic and open surgery group
was (32 ± 12) and (35 ± 1) respectively, with noFigure 5 Distribution of harvested perigastric lymph nodes laparosco
gastrectomy(OTG) groups. The mean number of removed lymph nodes
(P > 0.05).statistically significance difference. Martínez-Ramos [13]
presented a meta-analysis comparing laparoscopy to
open surgery, predominantly in AGC. The study demon-
strated no significant differences between the two groups
in the number of dissected lymph nodes (weighted meanpy-assisted total gastrectomy (LATG) and the open total
in each station was not significantly different between the two groups.
Figure 6 Overall survival curves for patients in the laparoscopy-assisted and the open gastrectomy groups. There were no significant
differences in overall survival curve between the two groups (P = 0.297).
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to 0.26, I-squared = 8.3). There studies suggested that
LAG D2 radical surgery for AGC is feasible and safe and
the number of harvested lymph nodes is the same as in
open surgery. We found that skilled laparoscopic surgi-
cal technology and thorough palpation of anatomical
layers under laparoscopy is the key to lymph node dis-
section. The laparoscopic amplification elaborately
shows the finer structure of the vasculature, nerves and
fascia, which helps surgeons to seek a specific fascia
space and facilitates lymph nodes dissection in the vas-
cular sheath. Furthermore, the ultrasonic scalpel is ef-
fective for cutting, for hemostasis and for minimizing
damage to the surrounding tissues, which is suitable for
vascular separation and lymph node dissection. The
number of resected lymph nodes in our study was
enough for curability and to determine lymph node me-
tastasis. Our data show that the mean number of
retrieved lymph nodes was not different between the
LAG and OG group. Furthermore, the mean number of
removed lymph nodes in each station was not signifi-
cantly different with distal or total gastrectomy. For
AGC without invasion of serosa, laparoscopy-assisted
D2 lymphadenetomy is able to achieve the same effect
on lymph node dissection as open surgery, regardless of
the extent of the gastrectomy. The surgical approach
(laparoscopy or open) did not appear to influence the
lymph node yield.
To date, laparoscopic surgery for early gastric carcin-
oma has achieved favorable short- and long-term effi-
cacy [6-8,24,25]. Although the efficacy of laparoscopicsurgery for AGC is rarely reported, the results also show
it can achieve almost the same short- and long-term effi-
cacy as open surgery. Hur [26] compared 26 cases of
laparoscopic surgery and 25 cases of open surgery for
treatment of AGC. The 3-year survival rate in the lapar-
oscopy and open surgery groups was 88.2% and 77.2%re-
spectively, with no statistical difference. A case–control
study reported by Shuang [27] demonstrated the same
survival curve for laparoscopy versus open surgery dur-
ing the same period and showed that laparoscopic sur-
gery has similar long-term efficacy for treatment of
AGC. Our study also showed that the survival curves for
the LAG and OG groups were not significantly different
(P > 0.05). LAG and OG have similar short survival
times, but the long-term effect needs to be followed-up.
In summary, if surgeons are proficient in laparoscopic
surgical techniques and comply with the principles of
surgery, LAG D2 radical surgery can achieve similar, or
even better effects compared to open surgery, and can
achieve a comparative short-term clinical efficacy for
treatment of AGC without serosal invasion. To establish
laparoscopic surgery as a standard treatment for AGC,
multicenter randomized controlled trials comparing the
short- and long-term outcomes of laparoscopic versus
open surgery are necessary.
Conclusion
Our study confirms laparoscopy-assisted D2 radical gas-
trectomy is feasible, effective and has comparative onco-
logical efficacy compared with open gastrectomy for
advanced gastric cancer without serosal invasion.
Chen et al. World Journal of Surgical Oncology 2012, 10:248 Page 9 of 9
http://www.wjso.com/content/10/1/248Abbreviations
AGC: Advanced gastric cancer; ASA: American Society of Anesthesiologists;
LAG: Laparoscopy-assisted gastrectomy; LNS: Lymph nodes; OG: Open
gastrectomy; TNM: Tumor node, metastasis staging; TOSGS: Therapy-oriented
severity grading system; WMD: Weighted mean difference; UICC: Union for
International Cancer Control.
Competing interests
The authors declare they have no competing interests.
Authors' contributions
QYC, CMH and JXL conceived the study, analyzed the data, and drafted the
manuscript; CHZ helped revise the manuscript critically for important
intellectual content; PL, JWX, JBW and JL helped collect data and design the
study. All authors read and approved the final manuscript.
Received: 14 September 2012 Accepted: 4 November 2012
Published: 16 November 2012
References
1. Kitano S, Iso Y, Moriyama M, Sugimachi K: Laparoscopy-assisted Billroth I
gastrectomy. Surg Laparosc Endosc 1994, 4:146–148.
2. Lee JH, Han HS: A prospective randomized study comparing open vs
laparoscopy-assisted distal gastrectomy in early gastric cancer: early
results. Surg Endosc 2005, 19:168–173.
3. Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, Mahajna A:
Laparoscopic and open gastric resections for malignant lesions: a
prospective comparative study. Surg Endosc 2005, 19:933–938.
4. Sobin LH, Gospodarowicz MK, Wittekind C: TNM Classification of Malignant
Tumours. New York: Wiley; 2009.
5. Japanese Gastric Cancer Association: Japanese classification of gastric
carcinoma: 3rd English edition. Gastric Cancer 2011, 14:101–112.
6. Kitano S, Shiraishi N, Fujii K, Yasuda K, Inomata M, Adachi Y: A randomized
controlled trial comparing open vs laparoscopy-assisted distal
gastrectomy for the treatment of early gastric cancer: an interim report.
Surgery 2002, 131:S306–311.
7. Han HS, Kim YW, Yi NJ, Fleischer GD: Laparoscopy-assisted D2 subtotal
gastrectomy in early gastric cancer. Surg Laparosc Endosc Percutan Tech
2003, 13:361–365.
8. Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N: A multicenter study
on oncologic outcome of laparoscopic gastrectomy for early cancer in
Japan. Ann Surg 2007, 245:68–72.
9. Lee JH, Yom CK, Han HS: Comparison of long-term outcomes of
laparoscopy-assisted and open distal gastrectomy for early gastric
cancer. Surg Endosc 2009, 23:1759–1763.
10. Uyama I, Sugioka A, Fujita J, Komori Y, Matsui H, Hasumi A: Laparoscopic
total gastrectomy with distal pancreatosplenectomy and D2
lymphadenectomy for advanced gastric cancer. Gastric Cancer 1999,
2:230–234.
11. Uyama I, Sugioka A, Matsui H, Fujita J, Komori Y, Hasumi A: Laparoscopic
D2 lymph node dissection for advanced gastric cancer located in the
middle or lower third portion of the stomach. Gastric Cancer 2000,
3:50–55.
12. Scatizzi M, Kroning KC, Lenzi E, Moraldi L, Cantafio S, Feroci F: Laparoscopic
versus open distal gastrectomy for locally advanced gastric cancer: a
case–control study. Updates Surg 2011, 63:17–23.
13. Martinez-Ramos D, Miralles-Tena JM, Cuesta MA, Escrig-Sos J, Van der Peet
D, Hoashi JS, Salvador-Sanchis JL: Laparoscopy versus open surgery for
advanced and resectable gastric cancer: a meta-analysis. Rev Esp Enferm
Dig 2011, 103:133–141.
14. Yoshimura F, Inaba K, Kawamura Y, Ishida Y, Taniguchi K, Isogaki J, Satoh S,
Kanaya S, Sakurai Y, Uyama I: Clinical outcome and clinicopathological
characteristics of recurrence after laparoscopic gastrectomy for
advanced gastric cancer. Digestion 2011, 83:184–190.
15. Roukos DH, Lorenz M, Encke A: Evidence of survival benefit of extended
(D2) lymphadenectomy in western patients with gastric cancer based on
a new concept: a prospective long-term follow-up study. Surgery 1998,
123:573–578.
16. Di Martino N, Izzo G, Cosenza A, Vicenzo L, Monaco L, Torelli F, Basciotti A,
Brillantino A, Marra A: Total gastrectomy for gastric cancer: can the typeof lymphadenectomy condition the long-term results? Suppl Tumori 2005,
4:S84–S85. Article in Italian.
17. Du XH, Li R, Chen L, Shen D, Li SY, Guo Q: Laparoscopy-assisted D2 radical
distal gastrectomy for advanced gastric cancer: initial experience. Chin
Med J (Engl) 2009, 122:1404–1407.
18. Tokunaga M, Hiki N, Fukunaga T, Nohara K, Katayama H, Akashi Y, Ohyama
S, Yamaguchi T: Laparoscopy-assisted distal gastrectomy with D2 lymph
node dissection following standardization–a preliminary study.
J Gastrointest Surg 2009, 13:1058–1063.
19. Japanese Gastric Cancer Association: Japanese gastric cancer treatment
guidelines 2010 (ver. 3). Gastric Cancer 2011, 14:113–123.
20. Kunisaki C, Makino H, Yamamoto N, Sato T, Oshima T, Nagano Y, Fujii S,
Akiyama H, Otsuka Y, Ono HA, Kosaka T, Takagawa R, Shimada H: Learning
curve for laparoscopy-assisted distal gastrectomy with regional lymph
node dissection for early gastric cancer. Surg Laparosc Endosc Percutan
Tech 2008, 18:236–241.
21. Yoo CH, Kim HO, Hwang SI, Son BH, Shin JH, Kim H: Short-term outcomes
of laparoscopic-assisted distal gastrectomy for gastric cancer during a
surgeon's learning curve period. Surg Endosc 2009, 23:2250–2257.
22. Zhang X, Tanigawa N: Learning curve of laparoscopic surgery for gastric
cancer, a laparoscopic distal gastrectomy-based analysis. Surg Endosc
2009, 23:1259–1264.
23. Sato H, Shimada M, Kurita N, Iwata T, Nishioka M, Morimoto S, Yoshikawa K,
Miyatani T, Goto M, Kashihara H, Takasu C: Comparison of long-term
prognosis of laparoscopy-assisted gastrectomy and conventional open
gastrectomy with special reference to D2 lymph node dissection.
Surg Endosc 2012, 26:2240–2246.
24. Yasuda K, Shiraishi N, Etoh T, Shiromizu A, Inomata M, Kitano S: Long-term
quality of life after laparoscopy-assisted distal gastrectomy for gastric
cancer. Surg Endosc 2007, 21:2150–2153.
25. Liang Y, Li G, Chen P, Yu J, Zhang C: Laparoscopic versus open
gastrectomy for early distal gastric cancer: a meta-analysis. ANZ J Surg
2011, 81:673–680.
26. Hur H, Jeon HM, Kim W: Laparoscopy-assisted distal gastrectomy with D2
lymphadenectomy for T2b advanced gastric cancers: three years'
experience. J Surg Oncol 2008, 98:515–519.
27. Shuang J, Qi S, Zheng J, Zhao Q, Li J, Kang Z, Hua J, Du J: A case–control
study of laparoscopy-assisted and open distal gastrectomy for advanced
gastric cancer. J Gastrointest Surg 2011, 15:57–62.
doi:10.1186/1477-7819-10-248
Cite this article as: Chen et al.: Laparoscopy-assisted versus open D2
radical gastrectomy for advanced gastric cancer without serosal
invasion: a case control study. World Journal of Surgical Oncology 2012
10:248.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
